Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

ATRACURIUM BESYLATE INJECTION

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ATRACURIUM BESYLATE INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ATRACURIUM BESYLATE INJECTION has been permanently discontinued (last updated October 15, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ATRACURIUM BESYLATE INJECTION not available?

The reason the manufacturer reported: Raw material availability.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusPermanently Discontinued
Same-ingredient products on file1 product · 0 same form & route
Report last updated2019-10-15
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CISATRACURIUM BESYLATE INJECTION USP MULTI-DOSE

STERIMAX INC

2MG · DIN 02563266

Not enough data to compareNot enough data to compareNot enough data to compareNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02236759

Active Ingredient

ATRACURIUM BESYLATE

See all ATRACURIUM BESYLATE products →

Shortage History